Ayala Pharmaceuticals Overview
- Year Founded
-
1987

- Status
-
Private
- Employees
-
15

- Latest Deal Type
-
2PO
- (Cancelled)
- Financing Rounds
-
17
- Investments
-
1
Ayala Pharmaceuticals General Information
Description
Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate-Specific Antigen (PSA) associated with prostate cancer.
Contact Information
Website
www.ayalapharma.comCorporate Office
- 1007 North Orange Street
- 4th Floor
- Wilmington, DE 19802
- United States
Corporate Office
- 1007 North Orange Street
- 4th Floor
- Wilmington, DE 19802
- United States
Ayala Pharmaceuticals Comparisons
Industry
Financing
Details
Ayala Pharmaceuticals Competitors (154)
One of Ayala Pharmaceuticals’s 154 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland | ||||
Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
ImmunityBio | Formerly VC-backed | San Diego, CA |
Ayala Pharmaceuticals Signals
Ayala Pharmaceuticals Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Ayala Pharmaceuticals Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Ayala Pharmaceuticals (Listeria Monocytogenes Immuno-Oncology And Related IP Assets) | Wilmington, DE |
Ayala Pharmaceuticals FAQs
-
When was Ayala Pharmaceuticals founded?
Ayala Pharmaceuticals was founded in 1987.
-
Where is Ayala Pharmaceuticals headquartered?
Ayala Pharmaceuticals is headquartered in Wilmington, DE.
-
What is the size of Ayala Pharmaceuticals?
Ayala Pharmaceuticals has 15 total employees.
-
What industry is Ayala Pharmaceuticals in?
Ayala Pharmaceuticals’s primary industry is Biotechnology.
-
Is Ayala Pharmaceuticals a private or public company?
Ayala Pharmaceuticals is a Private company.
-
What is Ayala Pharmaceuticals’s current revenue?
The current revenue for Ayala Pharmaceuticals is
. -
How much funding has Ayala Pharmaceuticals raised over time?
Ayala Pharmaceuticals has raised $211M.
-
Who are Ayala Pharmaceuticals’s investors?
Crede Capital Group, Arc Ventures (United States), and BioSight have invested in Ayala Pharmaceuticals.
-
Who are Ayala Pharmaceuticals’s competitors?
CytomX Therapeutics, CRISPR Therapeutics, Inovio Pharmaceuticals, Sorrento Therapeutics, and ImmunityBio are some of the 154 competitors of Ayala Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »